Thank you, Gary. It's been such a privilege to work alongside our leadership team and the talented professionals on our finance team. As I prepare to step down, I look-forward to supporting Karian during this transition. I am confident in her capability to guide our finance organization forward, drawing on her deep understanding of our business and her thoughtful approach that will serve our team well in the years ahead. Turning to our Q3 results. As David noted, my review of our financial performance and outlook will be done on a non-GAAP basis. Unless otherwise noted, each mention of gross margin, operating expense, operating income and loss, operating margin and net income and loss per share will mean the corresponding non-GAAP metric. Our Q3 results reflect what continues to be a challenging consumer spend environment with intensified competition in our market segment. But as Gary mentioned, we are greatly encouraged that our results demonstrate the success of our restructuring efforts and our steady progress in driving significant margin improvements. Our third quarter 2024 revenue totaled $193.4 million compared with $186.2 million in Q3 of 2023. The year-over-year increase was due to the timing of certain large orders. Geographically, in the third quarter, revenue increased 23% in the US, declined 20% in Japan and declined 11% in EMEA. Our Japan results reflect continued weakness in the yen against the dollar. Excluding the unfavorable foreign currency impact, Japan revenue decreased 15% over the prior year period. In terms of product mix, two-in-one products represented 57% of total robot sales in Q3. Accessory revenue in the quarter declined 8% over the prior year and represented approximately 8% of total revenue. Revenue from mid-tier robots with an MSRP between $300 and $499 and premium robots with an MSRP of $500 or more represented 79% of total robot sales compared with 80% in the year-ago period. Our third quarter direct-to-consumer or D2C sales decreased slightly by 1% from the year-ago period with flat sales in North America and a 9% increase in EMEA, offset by an 8% decline in Japan. In the third quarter, our D2C revenue represented 19% of total revenue as compared to 20% of total revenue a year ago. Q3 gross margin was 32.4%, up from 26.5% in the third quarter of 2023. Overall, we remain on track with our gross margin improvement plan, which is driven by new products with a better cost profile, as well as cost reductions on existing products. Looking at Q4, we expect a sequential decline in gross margin due to seasonal promotional activities, but anticipate strong year-over-year improvement. Operating expenses for Q3 2024 totaled $47.7 million compared with $90.1 million in the year ago period, representing a 47% year-over-year reduction. As a percentage of sales, operating expenses decreased by 2,370 basis points from a year ago. Operating expenses in the third quarter include a benefit of $13.5 million or 700 basis points, specifically from a favorable IP litigation settlement. This is a one-time benefit and underscores the overall strength of our IP portfolio. In addition to the benefit from the settlement, this operating expense decrease primarily reflects the progress in our aggressive and ongoing restructuring efforts along with disciplined spending in the quarter. The key drivers of the reduction were people-related spending across all functions, reduced marketing spend and a continued focus on efficiencies across the company. Our Q3 GAAP results include a $1.9 million charge related to our restructuring plan, primarily for severance and related costs. In the first nine months of the year, we reduced operating expenses by $95.2 million, which includes the $13.5 million IP litigation settlement and made significant progress in achieving the full year expense reduction goals for R&D, sales and marketing and headcount that we set out in February. Cost reductions are part of our ongoing strategy to right size the business and position it for sustainable growth. We continue to remain focused on reducing our operating and cash-flow losses and achieving our targets for positive operating income and cash-flow from operations. In the first three quarters, we exceeded our targets and reduced R&D expenses by $33.1 million compared to a full-year target reduction of approximately $25 million. In the same-period, we reduced overall sales and marketing expenses by $38.2 million, including $19 million in working marketing compared with a full-year reduction of $40 million, which included a decrease in working marketing of approximately $20 million. As Gary noted, including our most recent workforce reduction, we have reduced our headcount by approximately 560 or approximately 50% versus year-end 2023. Turning to operating income. For Q3, we reported operating income of $15.1 million compared with an operating loss of $40.6 million in the year-ago period. For the nine month period, we reported an operating loss of $73.1 million compared with an operating loss of $153.4 million. Please note that these 2024 figures include the $13.5 million benefit from the IP litigation settlement during the third quarter. Third quarter non-operating expense was $12.5 million, reflecting interest expense and the impact of fair-value accounting associated with our term-loan. This was partially offset by interest income on cash balances. Our Q3 tax expense was $1.5 million and net income per share was $0.03. This compares with a Q3 net loss per share a year-ago of $2.82. The $13.5 million IP litigation settlement had a positive one-time impact to earnings of $0.44 per share. We ended Q3 with $99.4 million in cash and cash equivalents, a decline of $9.1 million from the end of Q2. Restricted cash totaled $41.1 million with $40 million set aside for future repayment of the term loan and subject to limited rights for inventory purchases. Our third quarter inventory levels reflect the seasonality of the business and preparations for the upcoming holiday season. At the close of the third quarter, the company elected to draw down $40 million of the restricted cash to purchase inventory. That cash was received in October and will be reflected in our fourth quarter results and under the terms of the loan agreement has a five month repayment period. In Q3, our cash used in operations was $10.2 million compared with $21.7 million in Q2 of this year and $55.5 million a year-ago. Third quarter DSO was 48 days compared with 36 days in the year-ago period due primarily to customer mix. Our quarter end inventory balance was $149.2 million or 104 days, a reduction of $95 million versus the prior year and reflects our continued focus on carefully managing inventory balances. As discussed on our Q1 call, we filed a Shelf S-3 registration settlement in February to enhance our liquidity and provide capital planning flexibility. The shelf offering includes an at-the-market or ATM offering program for the sale of the company's common stock. During the third quarter, we sold 0.2 million shares for total net proceeds of $1.4 million. As of the end of Q3, we had $79.6 million remaining under the ATM program. In all, we have continued to make progress in managing our key working capital levers, while prioritizing careful management of our working capital efficiency. As Gary mentioned, we recognize that this is a challenging macroeconomic environment for consumers and that it's not likely to change before the end-of-the holiday shopping season, which will be shorter given the timing of Thanksgiving this year. With that in mind, we are providing our fourth quarter outlook and revising our full-year outlook. For Q4, we expect revenue in the range of $175 million to $200 million and gross margin in the range of 24% to 27%, up from 18.9% in Q4 2023. Operating loss is expected to be in the range of $31 million to $22 million and net loss per share is expected to be in the range of $1.50 to $1.20 per share. Our outlook reflects seasonal increases in promotional and marketing expenses, particularly as we plan for the anticipated 2025 rollout of new products. For full year 2024, we are lowering our guidance as a result of persistent headwinds in the consumer market and ongoing competitive challenges. We now expect revenue to be in the range of $685 million to $710 million and gross margin in the range of 25% to 26%. We are targeting full-year operating expenses in the range of $274 million to $276 million or approximately 39% to 40% of revenue. The anticipated decrease from full-year 2023 primarily reflects previously announced efforts to align our cost structure more closely with near-term revenue expectations, along with the additional workforce reduction this quarter. We anticipate full-year operating margin of approximately negative 15% to negative 13%. From a cash perspective, we continue to make incremental progress in improving our cash used in operations. Excluding the Amazon termination fee received in Q1 2024, we are expecting a significant improvement in cash-flow in the second-half of 2024 relative to the first-half of the year. In terms of other notable modeling assumptions for 2024, we anticipate other expense of around $38 million, including approximately $14 million in net interest expense and $24 million in estimated fair-value adjustment associated with our term-loan and full-year tax expense of approximately $3 million driven by our foreign jurisdiction. We anticipate a share count of approximately 29.6 million shares, exclusive of any additional issuances under our ATM. As a result, we expect a full-year net loss per share in the range of $4.91 to $4.60. Our business remains minimally capital-intensive and we now expect full-year capital spending to be less than $1 million. As a reminder, we manage our business on a full-year basis and continue to encourage investors to focus on our annual targets, given that the timing of orders is challenging to forecast even under ideal conditions. Large orders that shift from one quarter to the next can cause material fluctuations in our quarterly growth rates and cash-flow performance. Additionally, our revenue expectations for the remainder of the year contemplate a euro exchange rate of 1.10 and a Japanese yen exchange rate of 150 to 155. Looking further ahead, while we are continuing to be cautious about the macroeconomic environment, we are expecting to return to year-over-year organic top-line growth for full-year 2025 as we introduce new and revitalized products. We believe the second-half of 2025 will be stronger than the first-half of the year as our product lineup ramps-up. Our Q1 results will reflect a transitional period for our product-line. It's important to note that as we continue to execute on our restructuring activities, we expect to be in a strong position to leverage a significantly improved margin structure, along with anticipated revenue increases in 2025. Additionally, please note that we will be participating in the Raymond James TMT and Consumer Conference on December 9 in New York, as well as the Needham Growth Conference in January. Conference details will be announced by press release and posted to our Investor Relations website, and we hope to see you at one or both events. With that, I will turn the call back over to Gary.